These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36574024)

  • 1. RE: One-Year Romosozumab Treatment Followed by One-Year Denosumab Treatment for Osteoporosis in Patients on Hemodialysis: An Observational Study.
    Pazianas M
    Calcif Tissue Int; 2023 May; 112(5):628-629. PubMed ID: 36574024
    [No Abstract]   [Full Text] [Related]  

  • 2. Denosumab versus romosozumab for postmenopausal osteoporosis treatment.
    Kobayakawa T; Miyazaki A; Saito M; Suzuki T; Takahashi J; Nakamura Y
    Sci Rep; 2021 Jun; 11(1):11801. PubMed ID: 34083636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab.
    Kendler DL; Bone HG; Massari F; Gielen E; Palacios S; Maddox J; Yan C; Yue S; Dinavahi RV; Libanati C; Grauer A
    Osteoporos Int; 2019 Dec; 30(12):2437-2448. PubMed ID: 31628490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-Year Romosozumab Treatment Followed by One-Year Denosumab Treatment for Osteoporosis in Patients on Hemodialysis: An Observational Study.
    Saito T; Mizobuchi M; Kato T; Suzuki T; Fujiwara Y; Kanamori N; Makuuchi M; Honda H
    Calcif Tissue Int; 2023 Jan; 112(1):34-44. PubMed ID: 36287217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the duration of previous osteoporosis treatment on the effect of romosozumab treatment.
    Tominaga A; Wada K; Okazaki K; Nishi H; Terayama Y; Kodama Y; Kato Y
    Osteoporos Int; 2022 Jun; 33(6):1265-1273. PubMed ID: 35059774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comment on One-Year Romosozumab Treatment Followed by One-Year Denosumab Treatment for Osteoporosis in Patients on Hemodialysis: An Observational Study.
    Ogata M; Sumi H; Shiizaki K; Tominaga N
    Calcif Tissue Int; 2023 Aug; 113(2):254-255. PubMed ID: 37076702
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of prior osteoporosis treatment on the treatment response of romosozumab followed by denosumab in patients with postmenopausal osteoporosis.
    Ebina K; Etani Y; Tsuboi H; Nagayama Y; Kashii M; Miyama A; Kunugiza Y; Hirao M; Okamura G; Noguchi T; Takami K; Goshima A; Miura T; Fukuda Y; Kurihara T; Okada S; Nakata K
    Osteoporos Int; 2022 Aug; 33(8):1807-1813. PubMed ID: 35362725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Romosozumab Treatment in Postmenopausal Women with Osteoporosis.
    Cosman F; Crittenden DB; Adachi JD; Binkley N; Czerwinski E; Ferrari S; Hofbauer LC; Lau E; Lewiecki EM; Miyauchi A; Zerbini CA; Milmont CE; Chen L; Maddox J; Meisner PD; Libanati C; Grauer A
    N Engl J Med; 2016 Oct; 375(16):1532-1543. PubMed ID: 27641143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased bone mineral density for 1 year of romosozumab, vs placebo, followed by 2 years of denosumab in the Japanese subgroup of the pivotal FRAME trial and extension.
    Miyauchi A; Dinavahi RV; Crittenden DB; Yang W; Maddox JC; Hamaya E; Nakamura Y; Libanati C; Grauer A; Shimauchi J
    Arch Osteoporos; 2019 Jun; 14(1):59. PubMed ID: 31168657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of romosozumab versus denosumab treatment on bone mineral density after 1 year in rheumatoid arthritis patients with severe osteoporosis: A randomized clinical pilot study.
    Mochizuki T; Yano K; Ikari K; Hiroshima R; Okazaki K
    Mod Rheumatol; 2023 Apr; 33(3):490-495. PubMed ID: 35689558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone Histomorphometry in an Osteoporotic Hemodialysis Patient Treated With Denosumab.
    Ibuki Y; Hukuda T; Tabata S; Ito A
    Ther Apher Dial; 2018 Jun; 22(3):302-304. PubMed ID: 28594111
    [No Abstract]   [Full Text] [Related]  

  • 12. When and how to stop denosumab therapy in a patient with osteoporosis.
    Goulden EL; Crowley RK
    Clin Endocrinol (Oxf); 2023 May; 98(5):649-653. PubMed ID: 35470448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Romosozumab and antiresorptive treatment: the importance of treatment sequence.
    Cosman F; Kendler DL; Langdahl BL; Leder BZ; Lewiecki EM; Miyauchi A; Rojeski M; McDermott M; Oates MK; Milmont CE; Libanati C; Ferrari S
    Osteoporos Int; 2022 Jun; 33(6):1243-1256. PubMed ID: 35165774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Osteoporosis].
    Uebelhart B; Ferrari S
    Rev Med Suisse; 2017 Jan; 13(544-545):88-90. PubMed ID: 28703545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Romosozumab: A Review in Postmenopausal Osteoporosis.
    Paik J; Scott LJ
    Drugs Aging; 2020 Nov; 37(11):845-855. PubMed ID: 32909197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verification of efficacy and safety of ibandronate or denosumab for postmenopausal osteoporosis after 12-month treatment with romosozumab as sequential therapy: The prospective VICTOR study.
    Kobayakawa T; Miyazaki A; Takahashi J; Nakamura Y
    Bone; 2022 Sep; 162():116480. PubMed ID: 35787482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Denosumab mid-term densitometric gain in postmenopausal osteoporosis women in clinical practice: comment on "Variability of denosumab densitometric response in postmenopausal osteoporosis".
    Torrente-Segarra V; Roig-Vilaseca D
    Rheumatol Int; 2018 Jun; 38(6):1161-1162. PubMed ID: 29546636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denosumab--a new option in the treatment of osteoporosis.
    Franek E
    Endokrynol Pol; 2011; 62(1):79-83. PubMed ID: 21365584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Romosozumab followed by denosumab in Japanese women with high fracture risk in the FRAME trial.
    Miyauchi A; Hamaya E; Yang W; Nishi K; Libanati C; Tolman C; Shimauchi J
    J Bone Miner Metab; 2021 Mar; 39(2):278-288. PubMed ID: 33057807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The sequential therapy of romosozumab followed by denosumab for osteoporosis.].
    Ono K; Tanaka S
    Clin Calcium; 2019; 29(3):357-362. PubMed ID: 30814382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.